ClinConnect ClinConnect Logo
Search / Trial NCT01784562

Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Launched by BAYER · Feb 4, 2013

Trial Information

Current as of April 25, 2025

No longer available

Keywords

Chronic Thromboembolic Pulmonary Hypertension

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - Male and female patients with CTEPH either inoperable or with persistent or recurrent PH after surgery
  • Exclusion Criteria:
  • All types of pulmonary hypertension other than Dana Point Classification Group 4
  • Operable patients listed for PEA (Pulmonary Endarterectomy)

Trial Officials

Bayer Study Director

Study Director

Bayer

About Bayer

Bayer is a global healthcare and life sciences company dedicated to advancing health and well-being through innovative research and development. With a strong commitment to improving patient outcomes, Bayer conducts clinical trials across various therapeutic areas, including oncology, cardiology, and women's health. The company leverages cutting-edge science and technology to develop breakthrough therapies, while adhering to the highest standards of ethical practices and regulatory compliance. Through collaboration with healthcare professionals and research institutions, Bayer aims to bring transformative solutions to the market, ultimately enhancing the quality of life for patients worldwide.

Locations

Cleveland, Ohio, United States

Philadelphia, Pennsylvania, United States

Wien, , Austria

Bern, , Switzerland

Zürich, , Switzerland

Chicago, Illinois, United States

Amsterdam, , Netherlands

Madrid, , Spain

Barcelona, , Spain

Madrid, , Spain

Hamburg, , Germany

Tucson, Arizona, United States

Boston, Massachusetts, United States

New York, New York, United States

Montreal, Quebec, Canada

Toronto, Ontario, Canada

Houston, Texas, United States

Los Angeles, California, United States

Bruxelles Brussel, , Belgium

Leuven, , Belgium

La Jolla, California, United States

Baltimore, Maryland, United States

München, Bayern, Germany

Leipzig, Sachsen, Germany

Pavia, , Italy

Barcelona, , Spain

Umeå, , Sweden

Dallas, Texas, United States

Glasgow, , United Kingdom

Ann Arbor, Michigan, United States

Omaha, Nebraska, United States

Caen, , France

Hamburg, , Germany

Ottawa, Ontario, Canada

Sacramento, California, United States

El Paso, Texas, United States

Besancon, , France

Rouen, , France

Pessac, , France

Aurora, Colorado, United States

Regensburg, Bayern, Germany

Dresden, Sachsen, Germany

Sevilla, , Spain

Le Kremlin Bicetre, , France

Pittsburgh, Pennsylvania, United States

Coimbra, , Portugal

Graz, Steiermark, Austria

Innsbruck, Tirol, Austria

Gießen, Hessen, Germany

Hannover, Niedersachsen, Germany

St. Petersburg, , Russian Federation

Homburg, Saarland, Germany

St. Gallen, Sankt Gallen, Switzerland

Roma, , Italy

Almada, , Portugal

Columbus, Ohio, United States

Weston, Florida, United States

Newark, New Jersey, United States

Greifswald, Mecklenburg Vorpommern, Germany

Ankara, , Turkey

Köln, Nordrhein Westfalen, Germany

Lund, , Sweden

Nagoya, Aichi, Japan

Würzburg, , Germany

Brest, , France

Heidelberg, Baden Württemberg, Germany

Vandoeuvre Les Nancy, , France

Linköping, , Sweden

Newcastle Upon Tyne, Tyne And Wear, United Kingdom

Fairfield, Ohio, United States

Sheffield, South Yorkshire, United Kingdom

St. Petersburg, , Russian Federation

Lausanne, Vaud, Switzerland

Nieuwegein, , Netherlands

Montpellier, , France

Rotterdam, , Netherlands

Iowa City, Iowa, United States

Trieste, , Italy

Sendai, Miyagi, Japan

Chiba, , Japan

Bunkyo Ku, Tokyo, Japan

Praha 2, , Czech Republic

Cali, Valle Del Cauca, Colombia

Monterrey, Nuevo Leon, Mexico

Lisboa, , Portugal

Calgary, Alberta, Canada

Aarhus N, , Denmark

Bron, , France

Cambridge, Cambridgeshire, United Kingdom

Würzburg, Bayern, Germany

Novosibirsk, , Russian Federation

Glasgow, West Dunbartonshire, United Kingdom

Bogotá, Cundinamarca, Colombia

Providence, Rhode Island, United States

Novosibirsk, , Russian Federation

London, Ontario, Canada

Santa Fe De Bogotá, , Colombia

Mexico. D.F., Distrito Federal, Mexico

México D.F., Distrito Federal, Mexico

Istanbul, , Turkey

Izmir, , Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials